Sun Pharma Share Price Live Updates: Sun Pharma's Closing Value
23 Jun 2025 | 08:40:17 AM IST Welcome to the Sun Pharma Stock Liveblog, your real-time source for the latest updates and comprehensive analysis on a prominent stock. Dive into the current details of Sun Pharma, including: Last traded price 1665.1, Market capitalization: 399513.27, Volume: 2567882, Price-to-earnings ratio 36.56, Earnings per share 45.55. Our liveblog offers a complete overview of Sun Pharma through a blend of fundamental and technical indicators. Stay informed about breaking news that can shape Sun Pharma's performance in the market. Our market analysis and expert opinions empower you to make informed investment decisions. Join us as we unravel the potential of Sun Pharma in the ever-changing market landscape. The data points are updated as on 08:40:17 AM IST, 23 Jun 2025 Show more
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
13 hours ago
- Time of India
Nestle India Share Price Live Updates: Nestle India finishes at Rs 2360.4
23 Jun 2025 | 08:57:24 AM IST Welcome to the Nestle India Stock Liveblog, your go-to platform for real-time updates and analysis on a top-performing stock. Stay ahead of the market with our in-depth coverage of Nestle India, including: Last traded price 2360.4, Market capitalization: 227579.66, Volume: 11470597, Price-to-earnings ratio 70.95, Earnings per share 33.27. Get a complete picture of Nestle India's performance through our comprehensive blend of fundamental and technical indicators. Stay informed about breaking news that can influence the stock's trajectory. Our liveblog equips you with the knowledge and insights needed to make confident investment decisions. Don't miss out on the latest updates as Nestle India continues to make waves in the market. The data points are updated as on 08:57:24 AM IST, 23 Jun 2025 Show more
Time of India
13 hours ago
- Time of India
Sun Pharma Share Price Live Updates: Sun Pharma's Closing Value
23 Jun 2025 | 08:40:17 AM IST Welcome to the Sun Pharma Stock Liveblog, your real-time source for the latest updates and comprehensive analysis on a prominent stock. Dive into the current details of Sun Pharma, including: Last traded price 1665.1, Market capitalization: 399513.27, Volume: 2567882, Price-to-earnings ratio 36.56, Earnings per share 45.55. Our liveblog offers a complete overview of Sun Pharma through a blend of fundamental and technical indicators. Stay informed about breaking news that can shape Sun Pharma's performance in the market. Our market analysis and expert opinions empower you to make informed investment decisions. Join us as we unravel the potential of Sun Pharma in the ever-changing market landscape. The data points are updated as on 08:40:17 AM IST, 23 Jun 2025 Show more
India.com
3 days ago
- India.com
Meet woman, daughter of India's richest pharma tycoon, she now leads Rs 3950000000000 company, she is…, her business is…
Vidhi Shanghvi, Sun Pharma Vidhi Shanghvi is daughter of Dilip Shanghvi, a famous Pharma businessman. She is in headlines for her role in Sun Pharma, one of India's biggest pharmaceutical companies. His net worth is around $25 billion and known as India's richest pharma billionaire. He is also among the top 100 richest people in the world. But now, his daughter Vidhi Shanghvi has also started handling his business. Who Is Vidhi Shanghvi? Vidhi Shanghvi is an Executive Director in Sun Pharma. After 13 years of experience, she now leads Sun Pharma's Consumer Healthcare and India Distribution. Sun Pharma was founded by her father, Dilip Shanghvi in 1983. They started making psychiatric drugs and slowly became India's most valuable pharma company, with a market capitalisation of Rs 3.95 lakh crore. Vidhi was recently appointed as Whole-time Director for a five-year term. Vidhi Shanghvi Educational Background Vidhi graduated from the Wharton School at the University of Pennsylvania. In Sun Pharma, she used her education in marketing and consumer healthcare. She began her career at Sun Pharma in 2012 as a Brand Manager in the India Business division. Over the years, she has held several leadership positions. In 2014, she became the Marketing Head for one of the company's Cardiovascular Business Units. She also handled many marketing campaigns. After the merger of Ranbaxy with Sun Pharma, Vidhi Shanghvi became the Business Head of the company's Consumer Healthcare Division. She has played a big role in the growth of the products like Revital H and Volini in retail stores, pharmacies, and online platforms in India. She also has expertise in various fields like marketing, brand building, project and alliance management, and distribution. She is the founder of Mann Talks, a not-for-profit mental health initiative. This platform gives free, holistic mental health solutions to individuals for their mental well-being.
